文献速递前列腺癌

前列腺癌治疗咨询中副作用沟通的差异

Variation in communication of side effects in prostate cancer treatment consultations.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-02-23

研究对一家三级转诊学术中心的9名多学科医生进行的50次初诊前列腺癌治疗咨询进行转录,定性分析医生沟通副作用的方式。结果显示,副作用常被省略、未量化或缺乏时间线,专科一致性(而非肿瘤风险)与更高沟通精细度相关。作者建议医生应阐明、量化并赋予副作用时间线以优化共享决策。

要点

  • 手术咨询中,勃起功能障碍和尿失禁分别有15%和12%被省略,仅30%和49%量化并带时间线。
  • 放疗咨询中,其他放疗后副作用64-67%被省略,仅3-8%量化并带时间线。
  • 专科一致性(而非肿瘤风险)与更高沟通精细度相关。

核心结论

  • 在本样本中,副作用在治疗咨询中常被省略、未量化或缺乏时间线。
  • 作者建议医生应阐明、量化并赋予副作用时间线以优化共享决策。

研究设计与样本

  • 定性研究,转录了来自一家三级转诊学术中心的9名多学科提供者(泌尿外科医生、放射肿瘤科医生、肿瘤内科医生)的50次初诊前列腺癌治疗咨询。

主要发现

  • 在讨论手术的咨询(n=40)中,勃起功能障碍和尿失禁分别在15%和12%的咨询中被省略,在47%和30%中未量化(仅名称或泛化),在8%和8%中记录为无时间线的平均发生率;仅30%和49%分别以带时间线的平均发生率或精确估计进行量化。
  • 在讨论放疗的咨询(n=36)中,刺激性泌尿症状、勃起功能障碍和其他放疗后副作用分别在22%、42%和64-67%的咨询中被省略,在61%、33%和23-28%中未量化,在8%、22%和6-8%中记录为无时间线的平均发生率;仅3-8%的放疗后副作用以带时间线的方式量化。
  • 专科一致性(而非肿瘤风险)与更高沟通精细度相关,尽管医生经常未能量化专科一致的副作用。

关键数值与推荐

  • 沟通精细度分级:(1)未提及,(2)仅名称,(3)泛化(“高”),(4)无时间点的平均发生率,(5)带时间点的平均发生率,(6)精确估计。

临床怎么用

  • 作者建议医生应阐明、量化并赋予副作用时间线以优化共享决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. We sought to qualitatively characterize how physicians communicate SE in consultations. METHODS: We transcribed 50 initial prostate cancer treatment consultations across nine multidisciplinary providers (Urologists, Radiation Oncologists, Medical Oncologists) at our tertiary referral, academic center. Coders identified quotes describing SE and used an inductive approach to establish a hierarchy for granularity of communication: (1) not mentioned, (2) name only, (3) generalization("high"), (4) average incidence without timepoint, (5) average incidence with timepoint, and (6) precision estimate. We reported the most granular mode of communication for each SE throughout the consultation overall and across specialty and tumor risk. RESULTS: Among consultations discussing surgery (n = 40), erectile dysfunction (ED) and urinary incontinence (UI) were omitted in 15% and 12%, not quantified (name only or generalization) in 47% and 30%, and noted as average incidence without timeline in 8% and 8%, respectively. In only 30% and 49% were ED and UI quantified with timeline (average incidence with timeline or precision estimate), respectively. Among consultations discussing radiation (n = 36), irritative urinary symptoms, ED, and other post-radiotherapy SE were omitted in 22%, 42%, and 64-67%, not quantified in 61%, 33%, and 23-28%, and noted as average incidence without timeline in 8%, 22%, and 6-8%, respectively. In only 3-8% were post-radiotherapy SE quantified with timeline. Specialty concordance (but not tumor risk) was associated with higher granularity of communication, though physicians frequently failed to quantify specialty-concordant SE. CONCLUSIONS: SE was often omitted, not quantified, and/or lacked a timeline in treatment consultations in our sample. Physicians should articulate, quantify, and assign a timeline for SE to optimize SDM.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Daskivich TJ, Naser-Tavakolian A, Gale R, et al. Variation in communication of side effects in prostate cancer treatment consultations. Prostate Cancer Prostatic Dis. 2024. PMID: 38396054. doi:10.1038/s41391-024-00806-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。